首页> 美国卫生研究院文献>PLoS Clinical Trials >β1-Adrenoceptor Autoantibodies from DCM Patients Enhance the Proliferation of T Lymphocytes through the β1-AR/cAMP/PKA and p38 MAPK Pathways
【2h】

β1-Adrenoceptor Autoantibodies from DCM Patients Enhance the Proliferation of T Lymphocytes through the β1-AR/cAMP/PKA and p38 MAPK Pathways

机译:DCM患者的β1-肾上腺素受体自身抗体通过β1-AR/ cAMP / PKA和p38 MAPK途径增强T淋巴细胞的增殖

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAutoantibodies against the second extracellular loop of the β1-adrenergic receptor (β1-AA) not only contribute to increased susceptibility to heart failure, but also play a causative role in myocardial remodeling through their sympathomimetic-like effects that are induced upon binding to the β1-adrenergic receptor. However, their role in the function of T lymphocytes has never been previously investigated. Our present study was designed to determine whether β1-AA isolated from the sera of dilated cardiomyopathy (DCM) patients caused the proliferation of T cells and the secretion of cytokines.
机译:背景针对β1-肾上腺素能受体(β1-AA)的第二个细胞外环的自身抗体不仅有助于增加对心力衰竭的敏感性,而且还通过与β1结合时产生的拟交感神经样作用在心肌重塑中发挥致病作用-肾上腺素能受体。但是,它们在T淋巴细胞功能中的作用以前从未被研究过。本研究旨在确定从扩张型心肌病(DCM)患者血清中分离出的β1-AA是否引起T细胞增殖和细胞因子的分泌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号